ALLIANCEBERNSTEIN L.P. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 289 filers reported holding MYRIAD GENETICS INC in Q3 2018. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q2 2024$2,810,332
+16.1%
114,895
+1.2%
0.00%0.0%
Q1 2024$2,420,033
+16.8%
113,510
+4.8%
0.00%0.0%
Q4 2023$2,072,288
+19.3%
108,2700.0%0.00%0.0%
Q3 2023$1,736,651
-30.8%
108,2700.0%0.00%0.0%
Q2 2023$2,509,699
-0.2%
108,2700.0%0.00%0.0%
Q1 2023$2,515,112
+44.2%
108,270
-9.9%
0.00%0.0%
Q4 2022$1,744,523
-22.8%
120,229
+1.5%
0.00%0.0%
Q3 2022$2,259,000
+1.7%
118,399
-3.1%
0.00%0.0%
Q2 2022$2,221,000
-25.3%
122,233
+3.5%
0.00%0.0%
Q1 2022$2,975,000
-8.5%
118,071
+0.3%
0.00%0.0%
Q4 2021$3,250,000
-14.2%
117,757
+0.4%
0.00%0.0%
Q3 2021$3,789,000
+2.2%
117,330
-3.2%
0.00%0.0%
Q2 2021$3,706,000
+6.1%
121,200
+5.6%
0.00%
-50.0%
Q1 2021$3,494,000
+56.3%
114,730
+1.5%
0.00%
+100.0%
Q4 2020$2,235,000
+51.6%
113,0200.0%0.00%0.0%
Q3 2020$1,474,000
+15.2%
113,020
+0.2%
0.00%0.0%
Q2 2020$1,280,000
-25.3%
112,850
-5.8%
0.00%0.0%
Q1 2020$1,714,000
-48.1%
119,800
-1.2%
0.00%
-50.0%
Q4 2019$3,302,000
-34.5%
121,260
-31.1%
0.00%
-33.3%
Q3 2019$5,038,000
-11.3%
175,980
-13.9%
0.00%
-25.0%
Q2 2019$5,679,000
-2.0%
204,420
+17.1%
0.00%0.0%
Q1 2019$5,797,000
+15.0%
174,620
+0.7%
0.00%0.0%
Q4 2018$5,041,000
-39.0%
173,420
-3.5%
0.00%
-20.0%
Q3 2018$8,265,000
+16.0%
179,669
-5.8%
0.01%0.0%
Q2 2018$7,126,000
+44.2%
190,678
+14.0%
0.01%
+25.0%
Q1 2018$4,941,000
-12.2%
167,220
+2.0%
0.00%0.0%
Q4 2017$5,630,000
-5.1%
163,9300.0%0.00%0.0%
Q3 2017$5,931,000
+42.1%
163,930
+1.5%
0.00%
+33.3%
Q2 2017$4,173,000
+118.4%
161,510
+62.3%
0.00%
+50.0%
Q1 2017$1,911,000
+7.5%
99,510
-6.7%
0.00%
+100.0%
Q4 2016$1,778,000
-34.3%
106,660
-18.8%
0.00%
-50.0%
Q3 2016$2,705,000
-36.8%
131,414
-6.1%
0.00%
-50.0%
Q2 2016$4,282,000
-14.0%
139,924
+5.2%
0.00%0.0%
Q1 2016$4,979,000
-5.2%
133,029
+9.3%
0.00%0.0%
Q4 2015$5,252,000
+10.5%
121,690
-4.1%
0.00%0.0%
Q3 2015$4,755,000
+10.1%
126,860
-0.1%
0.00%0.0%
Q2 2015$4,318,000
+148.0%
127,050
+158.3%
0.00%
+300.0%
Q1 2015$1,741,000
+2.3%
49,184
-1.6%
0.00%0.0%
Q4 2014$1,702,000
-19.5%
49,984
-8.8%
0.00%
-50.0%
Q3 2014$2,113,000
-0.3%
54,784
+0.6%
0.00%0.0%
Q2 2014$2,119,000
+12.6%
54,434
-1.1%
0.00%0.0%
Q1 2014$1,882,000
+75.2%
55,031
+7.5%
0.00%
+100.0%
Q4 2013$1,074,000
-13.7%
51,210
-3.3%
0.00%0.0%
Q3 2013$1,244,000
-11.6%
52,940
+1.1%
0.00%0.0%
Q2 2013$1,407,00052,3450.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
MANGROVE PARTNERS IM, LLC 250,000$5,875,0002.93%
MUHLENKAMP & CO INC 484,765$11,392,0002.26%
KESTREL INVESTMENT MANAGEMENT CORP 854,475$20,080,0002.06%
TEALWOOD ASSET MANAGEMENT INC 154,975$3,642,0001.61%
NEW AMSTERDAM PARTNERS LLC/NY 1,958,356$46,022,0001.54%
S&T BANK/PA 398,578$9,367,0001.46%
MAZAMA CAPITAL MANAGEMENT INC 87,580$2,058,0001.12%
RA Capital Management 450,000$10,575,0001.10%
Palisades Investment Partners, LLC 48,100$1,130,0001.06%
TIVERTON ASSET MANAGEMENT LLC 1,780,200$41,836,0001.01%
View complete list of MYRIAD GENETICS INC shareholders